tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AUTL Stock Latest News

Autolus Therapeutics price target lowered to $10 from $11 at Truist
The FlyAutolus Therapeutics price target lowered to $10 from $11 at Truist
2d ago
AUTL
Autolus Therapeutics: Positive Momentum Amid Financial Challenges
PremiumCompany Announcements
Autolus Therapeutics: Positive Momentum Amid Financial Challenges
13d ago
AUTL
Autolus Therapeutics price target lowered to $6 from $8 at Wells Fargo
PremiumThe Fly
Autolus Therapeutics price target lowered to $6 from $8 at Wells Fargo
13d ago
AUTL
Positive Outlook and Buy Rating for Autolus Therapeutics Driven by Strategic Developments and Promising Prospects
PremiumRatings
Positive Outlook and Buy Rating for Autolus Therapeutics Driven by Strategic Developments and Promising Prospects
13d ago
AUTL
Autolus Therapeutics Reports Strong 2024 Results
PremiumCompany Announcements
Autolus Therapeutics Reports Strong 2024 Results
13d ago
AUTL
Optimistic Buy Rating for Autolus Therapeutics Driven by Strategic Advancements and Successful Launch of Aucatzyl
PremiumRatingsOptimistic Buy Rating for Autolus Therapeutics Driven by Strategic Advancements and Successful Launch of Aucatzyl
14d ago
AUTL
Positive Outlook for Autolus Therapeutics Amidst Strategic Developments and Financial Strength
Premium
Ratings
Positive Outlook for Autolus Therapeutics Amidst Strategic Developments and Financial Strength
14d ago
AUTL
Autolus Therapeutics Launches AUCATZYL® in U.S. Market
Premium
Company Announcements
Autolus Therapeutics Launches AUCATZYL® in U.S. Market
14d ago
8K
AUTL
Autolus Therapeutics reports FY24 EPS (86c), consensus (91c)
PremiumThe Fly
Autolus Therapeutics reports FY24 EPS (86c), consensus (91c)
14d ago
AUTL
Autolus Therapeutics sees cash runway to data in clincal trial of obe-cel
PremiumThe Fly
Autolus Therapeutics sees cash runway to data in clincal trial of obe-cel
14d ago
AUTL
Is AUTL a Buy, Before Earnings?
PremiumPre-Earnings
Is AUTL a Buy, Before Earnings?
16d ago
AUTL
Autolus Therapeutics presents clinical data updates at Tandem Meetings
PremiumThe Fly
Autolus Therapeutics presents clinical data updates at Tandem Meetings
3M ago
AUTL
Autolus Therapeutics Gains FDA Approval for AUCATZYL
PremiumCompany AnnouncementsAutolus Therapeutics Gains FDA Approval for AUCATZYL
3M ago
8K
AUTL
Autolus Therapeutics provides business updates, 2025 overview
Premium
The Fly
Autolus Therapeutics provides business updates, 2025 overview
3M ago
AUTL
Autolus Therapeutics presents clinical data updates at ASH meeting
Premium
The Fly
Autolus Therapeutics presents clinical data updates at ASH meeting
4M ago
AUTL
Autolus Therapeutics announces publication of data from FELIX study
PremiumThe Fly
Autolus Therapeutics announces publication of data from FELIX study
4M ago
AUTL
Autolus Therapeutics upgraded to Buy from Neutral at Goldman Sachs
PremiumThe Fly
Autolus Therapeutics upgraded to Buy from Neutral at Goldman Sachs
5M ago
AUTL
Autolus Therapeutics upgraded to Buy from Neutral at Redburn Atlantic
PremiumThe Fly
Autolus Therapeutics upgraded to Buy from Neutral at Redburn Atlantic
5M ago
AUTL
Autolus Therapeutics Q3 2024 Financial Update and FDA Approval
PremiumCompany Announcements
Autolus Therapeutics Q3 2024 Financial Update and FDA Approval
5M ago
AUTL
Autolus Therapeutics Wins FDA Approval for AUCATZYL®
PremiumCompany AnnouncementsAutolus Therapeutics Wins FDA Approval for AUCATZYL®
5M ago
8K
AUTL
Autolus Therapeutics Gains FDA Approval for AUCATZYL®
Premium
Company Announcements
Autolus Therapeutics Gains FDA Approval for AUCATZYL®
5M ago
8K
AUTL
Autolus Therapeutics reports Q3 EPS (31c), consensus (21c)
Premium
The Fly
Autolus Therapeutics reports Q3 EPS (31c), consensus (21c)
5M ago
AUTL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >